Related Experiment Video
Updated: Aug 15, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Goal-oriented thrombolytic therapy for venous thromboembolic disease
Vijay Nambi1, Marcelo P V Gomes, Steven R Deitcher
1Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Clinical Advances in Hematology & Oncology : H&O
|September 17, 2005
Summary
Thrombolytic therapy for venous thromboembolic disease often relies on surrogate markers, not patient outcomes. Current evidence suggests reserving thrombolysis for severe cases due to risks like bleeding and unclear benefits for most patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Medical Interventions
Background:
- Therapeutic interventions should prioritize meaningful patient outcomes.
- Treatment efficacy is frequently assessed using surrogate endpoints rather than direct patient benefits.
- Thrombolytic therapy for venous thromboembolic disease often uses radiographic or echocardiographic markers.
Purpose of the Study:
- To evaluate the effectiveness of thrombolytic therapy for venous thromboembolic disease.
- To compare thrombolytic therapy outcomes with conventional anticoagulation.
- To determine appropriate clinical scenarios for thrombolytic therapy.
Main Methods:
- Review of current scientific evidence regarding thrombolytic therapy for venous thromboembolic disease.
- Analysis of clinical trial data comparing thrombolysis with anticoagulation.
- Assessment of surrogate endpoints versus meaningful patient outcomes.
Main Results:
- Thrombolysis for lower-extremity deep venous thrombosis does not decrease pulmonary embolism incidence and has uncertain effects on post-thrombotic syndrome.
- Thrombolytic therapy is associated with higher rates of major hemorrhage compared to anticoagulation.
- Evidence does not support routine thrombolysis for hemodynamically stable pulmonary embolism.
Conclusions:
- Thrombolytic therapy for venous thromboembolic disease should be reserved for limb-threatening cases, particularly in younger patients.
- Risks, benefits, and alternatives must guide treatment decisions.
- Therapy should be individualized based on patient circumstances and scientific evidence.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...